Latin America Vaccine Adjuvant Market by Type (Aluminium Salts, Tensoactive Adjuvants, Adjuvant Emulsions, Bacteria derived Adjuvants, Liposome Adjuvants and Carbohydrate Adjuvants) by Route of Administration (Oral, Intradermal, Subcutaneous, Intranasal and Intramuscular), by Mechanism of Action (Immuno Stimulants, Carriers and Vehicle Adjuvants) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Latin America Vaccine Adjuvant Market by Type (Aluminium Salts, Tensoactive Adjuvants, Adjuvant Emulsions, Bacteria derived Adjuvants, Liposome Adjuvants and Carbohydrate Adjuvants) by Route of Administration (Oral, Intradermal, Subcutaneous, Intranasal and Intramuscular), by Mechanism of Action (Immuno Stimulants, Carriers and Vehicle Adjuvants) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 681 | Pages: 141 | October 2016 | Region: Latin America


The Latin America Vaccine Adjuvant Market was worth $66.08 million in 2016 and estimated to be growing at a CAGR of 11.35%, to reach $113.12 million by 2021.

Adjuvants are used since decades to develop the immune response towards vaccine antigens. They perk up the body's immune response and regularly allow for slighter amounts of a deactivated virus or bacteria to be used in a vaccine. Though, more than one adjuvant may be present in the final vaccine product.

The necessity for these products will increase as adjuvants will be required to improve and spread immune responses while decreasing the quantity of antigen essential for each dose. The restricted immunogenicity of different and new vaccine antigens has amplified the significance of adjuvant research in vaccine improvement. There is a necessity for development of harmless and non-toxic adjuvants. Vaccines comprising of novel adjuvant formulations are progressively getting advanced development and started reaching licensing stages, providing new tools to fill previously unmet clinical needs. Conversely, many adjuvants miss the mark during product development due to factors such as unacceptable levels of tolerability or safety concerns, stability, lack of effectiveness and manufacturability.

The Latin America vaccine adjuvants market is segmented on the basis of type into Aluminium Salts, Tensoactive Adjuvants, Adjuvant emulsions, Bacteria derived Adjuvants, Liposome Adjuvants and Carbohydrate Adjuvants. Based on route of administration, the market is divided into oral, intradermal, subcutaneous, intranasal and intramuscular. The market is bifurcated on the basis of mechanism of action into active immuno stimulants, carriers and vehicle adjuvants. The intramuscular segment is expected to account for the largest share of the global vaccine adjuvants market in 2016.    

Based on geography the market is analysed under various regions namely, Brazil, Argentina and Mexico. Mexico is the leading country for the Latin America region in terms of market share and is expected to grow at highest CAGR in the forecast period.

The key players in the vaccine adjuvants market include MPV Technologies (U.S.), Avanti Polar Lipids, Novavax Inc. (U.S.), Inc. (U.S.), Brenntag Biosector (Denmark), SEPPIC (France), Agenus, Inc. (U.S.), Invivogen (U.S.), SPI Pharma, Inc. (U.S.), CSL Limited (Australia), and OZ Biosciences (France).

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 By Type                        

                                5.1.1 Aluminium Salts    

                                5.1.2 Tensoactive Adjuvants      

                                5.1.3 Adjuvant Emulsions            

                                5.1.4 Bacteria derived Adjuvants              

                                5.1.5 Liposome Adjuvants           

                                5.1.6 Carbohydrate Adjuvants   

                5.2 By Route of Administration                 

                                5.2.1 Oral            

                                5.2.2 Intradermal            

                                5.2.3 Subcutaneous       

                                5.2.4 Intranasal                

                                5.2.5 Intramuscular        

                5.3 By Mechanism of Action                       

                                5.3.1 Immuno Stimulants             

                                5.3.2 Carriers     

                                5.3.3 Vehicle Adjuvants

6. Geographical Analysis                                              

                                6.1 Introduction               

                                6.2 Brazil             

                                6.3 Mexico         

                                6.4 Argentina    

                                6.5 Rest of Latin America             

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 MPV Technologies                  

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues             

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Avanti Polar Lipids                   

                8.3 Novavax Inc.                              

                8.4 Brenntag Biosector                 

                8.5 SEPPIC                          

                8.6 Agenus, Inc.                               

                8.7 Invivogen                    

                8.8 SPI Pharma Inc.                         

                8.9 CSL Limited                 

                8.10 OZ Biosciences                        

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Expert Opinions                                        

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Latin America Vaccine Adjuvant Market By Region, From 2016-2021 (USD Million)
  2. Latin America Vaccine Adjuvant Market By Type, From 2016-2021 (USD Million)
  3. Latin America Aluminium Salts Market By Region, From 2016-2021 (USD Million)
  4. Latin America Tensoactive Adjuvants Market By Region, From 2016-2021 (USD Million)
  5. Latin America Adjuvant Emulsions Market By Region, From 2016-2021 (USD Million)
  6. Latin America Bacteria derived Adjuvants Market By Region, From 2016-2021 (USD Million)
  7. Latin America Liposome Adjuvants Market By Region, From 2016-2021 (USD Million)
  8. Latin America Carbohydrate Adjuvants Market By Region, From 2016-2021 (USD Million)
  9. Latin America Vaccine Adjuvant Market By Route of Administration , From 2016-2021 (USD Million)
  10. Latin America Oral Market By Region, From 2016-2021 (USD Million)
  11. Latin America Intradermal Market By Region, From 2016-2021 (USD Million)
  12. Latin America Subcutaneous Market By Region, From 2016-2021 (USD Million)
  13. Latin America Intranasal Market By Region, From 2016-2021 (USD Million)
  14. Latin America Intramuscular Market By Region, From 2016-2021 (USD Million)
  15. Latin America Vaccine Adjuvant Market By Mechanism of Action, From 2016-2021 (USD Million)
  16. Latin America Immuno Stimulants Market By Region, From 2016-2021 (USD Million)
  17. Latin America Carriers Market By Region, From 2016-2021 (USD Million)
  18. Latin America Vehicle Adjuvants Market By Region, From 2016-2021 (USD Million)
  19. Brazil Vaccine Adjuvant Market By Type, From 2016-2021 (USD Million)
  20. Brazil Vaccine Adjuvant Market By Route of Administration , From 2016-2021 (USD Million)
  21. Brazil Vaccine Adjuvant Market By Mechanism of Action, From 2016-2021 (USD Million)
  22. Argentina Vaccine Adjuvant Market By Type, From 2016-2021 (USD Million)
  23. Argentina Vaccine Adjuvant Market By Route of Administration , From 2016-2021 (USD Million)
  24. Argentina Vaccine Adjuvant Market By Mechanism of Action, From 2016-2021 (USD Million)
  25. Mexico Vaccine Adjuvant Market By Type, From 2016-2021 (USD Million)
  26. Mexico Vaccine Adjuvant Market By Route of Administration , From 2016-2021 (USD Million)
  27. Mexico Vaccine Adjuvant Market By Mechanism of Action, From 2016-2021 (USD Million)
Middle East And Africa Western Blotting Market By Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & ...
Latin America Western Blotting Market By Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & Biotechno...
Asia Pacific Western Blotting Market By Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & Biotechnol...
Europe Western Blotting Market By Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Co...
North America Western Blotting Market By Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & Biotechno...
Western Blotting Market By Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies...
Middle East And Africa Multiplex Assays Market By Product (Consumable, Kits & Reagents, Panels), Type (nucleic Acid-Based, Protein-Based), Technology (PCR, Multiplex Array), Application (R&D, Companion Diagnostics),...
Latin America Multiplex Assays Market By Product (Consumable, Kits & Reagents, Panels), Type (nucleic Acid-Based, Protein-Based), Technology (PCR, Multiplex Array), Application (R&D, Companion Diagnostics), End User...
Asia Pacific Multiplex Assays Market By Product (Consumable, Kits & Reagents, Panels), Type (nucleic Acid-Based, Protein-Based), Technology (PCR, Multiplex Array), Application (R&D, Companion Diagnostics), End User ...
Europe Multiplex Assays Market By Product (Consumable, Kits & Reagents, Panels), Type (nucleic Acid-Based, Protein-Based), Technology (PCR, Multiplex Array), Application (R&D, Companion Diagnostics), End User (Hospi...
North America Multiplex Assays Market By Product (Consumable, Kits & Reagents, Panels), Type (nucleic Acid-Based, Protein-Based), Technology (PCR, Multiplex Array), Application (R&D, Companion Diagnostics), End User...
Multiplex Assays Market By Product (Consumable, Kits & Reagents, Panels), Type (nucleic Acid-Based, Protein-Based), Technology (PCR, Multiplex Array), Application (R&D, Companion Diagnostics), End User (Hospital, Cl...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.